Investigation and Diagnosis of the Chromosome Variation in Donated/abandoned Blastocyst
NCT ID: NCT05216068
Last Updated: 2025-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2021-12-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Importance of Blastocyst Diamater and Its Correlation to Reproductive Outcomes in PGT-A Cases
NCT05499988
Study of the Best Blastocyst Post Transfer by aCGH
NCT01664546
The Effectiveness of Blastocentesis Versus Trophectoderm Biopsy
NCT02915276
PGT-A Versus Blastocyst Morphology Selection
NCT03095053
Clinical Application of Non-invasive PGT-A
NCT04856696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Collected 200 donate abandonment embryos: Five to six days after egg retrieval, well-developed embryos (called blastocysts).
2. Blastocysts derived from patients seeking infertility treatment were generated.
3. Embryos biopsies for PGT-A (by use of NGS platforms from our institute) will be used for the validation of our Lab QC embryo.
4. To standardize the operating procedures
5. Paper writing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
donated abandonment embryos
Embryos biopsies for PGT-A (by use of NGS platforms from our institute) will be used for the validation of our Lab QC.
NGS
Based on the next generation sequencing (NGS), WES can identify single nucleotide variants (SNVs) and small variants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NGS
Based on the next generation sequencing (NGS), WES can identify single nucleotide variants (SNVs) and small variants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* parents consent to donate the embryos
Exclusion Criteria
* whose embryo morphology and quality do not meet the technical requirements for genetic testing
20 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung Memorial Hospital
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMRPG8M0241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.